Food and Drug Administration Meeting of the Division of Bone, Reproductive, and Urologic Products in the Center for Drug Evaluation and Research.
The way we screen and treat osteoporosis is still deeply flawed. The NWHN thinks women deserve better, and we’re fighting to make that vision a reality.
Pharmaceutical companies trying to sell drugs have pushed for the adoption of flawed screening techniques that medicalized age-related bone loss. The result? Many healthy women were prescribed osteoporosis drugs despite their serious side effects and risks.
For decades, women’s health advocates have been concerned about the safety of Depo-Provera, the progesterone-based contraceptive shot (the shot).
Osteoporosis is a bone disease that makes one’s bones weak and more susceptible to break. It’s known as a silent disease. Most individuals develop osteoporosis, but the majority of individuals don’t know they have it, until they break a bone.